Who invested in Vensun Pharmaceuticals?
Vensun Pharmaceuticals's investors include LD Capital, Perceptive Advisors, Deerfield and JW Asset Management.
United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$59Mraised across 5 rounds since 2012, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $19M sold, first sale Nov 2016
No investor was named in the report.
From a historical funding recordSEC filing: $4.0M sold, first sale Sept 2015
From a historical funding recordSEC filing: $11M sold, first sale Oct 2013
No investor was named in the report.
Reported by bizjournals.comSEC filing: $11M sold, first sale Oct 2013
No investor was named in the report.
Reported by sec.govSEC filing: $5.7M sold, first sale Mar 2012
From the SEC filings it signed: 1 on the team.
On the board, as filediDhananjay G. WadekarEdward G. SchutterJason E. WildKamlesh E. HaribhaktiMichael G. AltmanSyed E. Abidi
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Vensun Pharmaceuticals's investors include LD Capital, Perceptive Advisors, Deerfield and JW Asset Management.
Vensun Pharmaceuticals has raised $59M across 5 rounds since 2012.
Vensun Pharmaceuticals's most recent round was a Series C of $23M in Dec 2016.
Its most recent round, $23M in Dec 2016, is also its largest on record.
Vensun Pharmaceuticals's first round on record, in Dec 2013, was backed by JW Asset Management.
Vensun Pharmaceuticals's latest named round is a Series C, in Dec 2016.
Vensun Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.